The positive regulatory machinery in the microRNA (miRNA) processing pathway is relatively well characterized, but negative regulation of the pathway is largely unknown. Here we show that a complex of nuclear factor 90 (NF90) and NF45 proteins functions as a negative regulator in miRNA biogenesis. Primary miRNA (pri-miRNA) processing into precursor miRNA (pre-miRNA) was inhibited by overexpression of the NF90 and NF45 proteins, and considerable amounts of pri-miRNAs accumulated in cells coexpressing NF90 and NF45. Treatment of cells overexpressing NF90 and NF45 with an RNA polymerase II inhibitor, ␣-amanitin, did not reduce the amounts of pri-miRNAs, suggesting that the accumulation of pri-miRNAs is not due to transcriptional activation. In addition, the NF90 and NF45 complex was not found to interact with the Microprocessor complex, which is a processing factor of primiRNAs, but was found to bind endogenous pri-miRNAs. NF90-NF45 exhibited higher binding activity for pri-let-7a than pri-miR-21. Of note, depletion of NF90 caused a reduction of pri-let-7a and an increase of mature let-7a miRNA, which has a potent antiproliferative activity, and caused growth suppression of transformed cells. These findings suggest that the association of the NF90-NF45 complex with pri-miRNAs impairs access of the Microprocessor complex to the pri-miRNAs, resulting in a reduction of mature miRNA production.
The NF90 family and NF45 proteins form a heterodimer and are predominantly localized in the nucleus.
NF90 and NF45 were first isolated as nuclear factors that bind to a cis element of the interleukin-2 promoter, known as an antigen receptor response element in the activated Jurkat T-cell line (27) . Independently, we previously identified NF90 as a binding factor that recognizes a unique palindromic sequence in the DNase I-hypersensitive site of the HLA-DR␣ gene in monocytic leukemia THP-1 cells (47) . The NF90 family proteins are also known to bind to a minihelix RNA derived from adenovirus VA RNA (17) . Interestingly, the secondary structures of both the palindromic sequence within the HLA-DR␣ gene and the minihelix RNA are predicted to be small double-stranded structures, similar to the structures of miRNA precursors (pri-and pre-miRNA).
As mentioned above, the NF90 and NF45 proteins associate with overexpressed Drosha, and NF90 favorably binds to the small double-stranded structures contained in the miRNA precursors. Therefore, NF90 and NF45 are highly likely to be involved in miRNA biogenesis, especially during processing of pri-miRNAs into pre-miRNAs. To investigate this possibility, we have examined the functions of the NF90 and NF45 proteins in the pri-miRNA processing step. Using an in vitro pri-miRNA processing assay, we found that forced expression of NF90 and NF45 inhibited the cleavage of pri-miRNAs into pre-miRNAs. Furthermore, pri-miRNAs accumulated in cells that coexpressed NF90 and NF45. In vivo binding analyses demonstrated that NF90 did not interact with the endogenous Drosha-DGCR8 complex, but the NF90-NF45 complex was bound to endogenous pri-miRNAs. Furthermore, this protein complex exhibited a higher affinity for pri-let-7a than primiR-21 in vitro. Interestingly, knockdown of NF90 caused a decrease in pri-let-7a and an increase in mature let-7a. Therefore, we propose that the association of the NF90-NF45 complex with pri-miRNAs may impair access of the Microprocessor complex to pri-miRNAs, resulting in the inhibition of the mature miRNA production.
MATERIALS AND METHODS
Sequences of all the oligonucleotides and PCR protocols are listed in Table S1 of the supplemental material.
Cells, plasmids, and antibodies. Human embryonic kidney 293T cells and 293 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. For expression of Flag-tagged NF90a, NF90b, NF110a, or NF110b proteins, cDNA fragments corresponding to the full length of these proteins were obtained by PCR from pcDNA3.1-NF90a,-NF90b, -NF110a, and -NF110b plasmids (provided by M. B. Mathews, University of Medicine and Dentistry of New Jersey, Newark). The cDNA fragments were subcloned into the EcoRI sites of the pcDNA3-Flag vector. To construct the Flag-tagged NF45 protein, a full-length NF45 cDNA was PCR amplified from HeLa cell cDNA and inserted into the EcoRI and XhoI sites of the pcDNA3-Flag vector. To construct an expression plasmid of Drosha, a full-length Drosha cDNA was obtained by PCR from HeLa cell cDNA and subcloned into BamHI and EcoRV sites of the pcDNA3.1 vector. Anti-Drosha, anti-DGCR8, antiKu70, and antitubulin antibodies were obtained from Upstate Biotechnology, ProteinTech Group, Inc., Santa Cruz Biotechnology, and CalBiochem, respectively. Anti-NF90 antibody was produced by immunizing New Zealand White rabbits with glutathione S-transferase-NF90 (residues 419 to 604) as previously described (53) .
Transfections. 293T cells were transfected using Lipofectamine Plus reagent according to the manufacturer's instructions (Invitrogen).
In vitro pri-miRNA processing assay. An in vitro pri-miRNA processing assay was performed as described by Lee et al. (35) with some modifications. Briefly, pri-miR-30a was amplified from 293T cDNA by PCR. The PCR product was subcloned into the pGEM-T-easy vector (Promega). The plasmid was linearized with SpeI and used for in vitro transcription to make a 32 P-radiolabeled RNA probe. Whole-cell extracts (WCEs) were prepared from 293T cells by sonication in lysis buffer (20 mM HEPES-KOH, pH 8.0, 100 mM KCl, 0.2 mM EDTA, 5% glycerol, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride [PMSF]), followed by centrifugation. Each 30-l reaction mixture contained the radiolabeled RNA probe, 100 g of WCE, 1 U RNase Out (Invitrogen), and 6.4 mM MgCl 2 in reaction buffer (20 mM HEPES-KOH, pH 8.0, 100 mM KCl, 0.2 mM EDTA, 5% glycerol). After incubation of the mixture at 37°C for 90 min, the resulting RNA was extracted and electrophoresed on a 12% denaturing polyacrylamide gel. The processed miRNAs were visualized by autoradiography. Intensities of the produced pre-miR-30a were measured using a BAS 2000 imaging system (Fuji Film).
Western blot analysis. Western blot analysis was performed as previously described (48) .
RNA interference. For the RNA interference experiment, 293 cells were transfected with small interfering RNAs (siRNAs) using Lipofectamine RNAiMAX according to the manufacturer's instructions (Invitrogen). siRNA duplexes targeting the NF90 family proteins were obtained from Invitrogen. As a negative control, Negative Universal Control Med (Invitrogen) was used.
qRT-PCR analysis. Total RNA was prepared by using TRIzol according to the manufacturer's instructions (Invitrogen). RNA was treated with DNase I (Ambion) for 20 min at 37°C, and DNase I was inactivated using DNase I Inactive reagent (Ambion). Two micrograms of DNase I-treated RNA was used to synthesize cDNA using a cDNA synthesis kit (Invitrogen). For quantitative reverse transcription-PCR (qRT-PCR), the PCR sample was comprised of diluted (1/ 160) cDNA, QuantiTect SYBR green PCR master mix (Qiagen), and 1 mM each of forward and reverse primers in a total volume of 12.5 l. PCRs were performed on a DNA Engine OPTICON 2 (MJ Research) using a cycling program. SYBR green PCR master mix (Applied Biosystems) was used when PCRs were performed on an ABI 7000 sequence detection system (Applied Biosystems). All runs included the ␤-actin gene as an internal control. Samples were normalized to ␤-actin RNA, giving arbitrary values representing a ratio of experimental to control results. Results are expressed as relative mRNA levels. qRT-PCR for detection of miRNA was carried out using a TaqMan MicroRNA assay kit (Applied Biosystems) according to the manufacturer's protocol. RNU6B small nuclear RNA was used as an internal control in the qRT-PCR to normalize RNA input.
Immunocytochemical staining. Immunocytochemical staining was performed as described by Muraki et al. (43) . The primary and secondary antibodies used were anti-NF90 antibody (10 g/ml) and fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulin G (IgG; 1:1,000; ICN), respectively. 4Ј,6-diamidino-2-phenylindole (DAPI) was used for nuclear staining. Stained cells were mounted with ProLong Gold antifade reagent (Invitrogen). Images were taken using a fluorescence microscope (Axiophoto; Carl Zeiss).
Immunoprecipitation. WCEs were prepared by lysing cells in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 0.1 mM PMSF, and protein inhibitor cocktail (Roche) and immunoprecipitated with anti-Drosha antibody or normal rabbit IgG. Immunoprecipitates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) and transferred to a polyvinylidene difluoride membrane. The membrane was probed with anti-Drosha, anti-DGCR8, or anti-NF90 antibodies. Following incubation, the membrane was washed and incubated with peroxidase-conjugated anti-rabbit IgG and subsequently developed by chemiluminescence using Western Lightning (PerkinElmer).
Blue native PAGE. Cells were resuspended with 1ϫ sample buffer (Invitrogen) including 1% n-dodecyl-␤-D-maltoside and incubated for 15 min at 0°C. After centrifugation (15,000 ϫ g) at 4°C for 20 min, the supernatants were collected as WCEs. The WCEs were mixed with 0.25% G-250 sample additive (Invitrogen) and subjected to electrophoresis on a native PAGE 4 to 16% bis-Tris gel (Invitrogen) and analyzed by Western blotting.
Detection of the interaction between the NF90-NF45 complex and pri-miRNA in vivo. WCEs from cells were immunoprecipitated with anti-FLAG affinity gel (Sigma), and the coprecipitated RNA was purified by proteinase K digestion, extracted with phenol-chloroform, and ethanol precipitated. The precipitated RNA was annealed with 250 ng/l random hexamers and reverse transcribed with the Reverse SuperScript III first-strand synthesis system (Invitrogen). cDNA was amplified by PCR using the specific primers for pri-miRNA. The primer sequences are described in Table S1 of the supplemental material.
Preparation of recombinant proteins. The full-length (FL) cDNAs of NF90 and NF45 were synthesized by PCR using pcDNA3.1-NF90b and pcDNA3.1-NF45 as templates, respectively. The DGCR8 FL cDNA was obtained by PCR using HeLa cDNA as a template. The PCR products were subcloned into pIVEX VOL. 29 .0, and 300 mM NaCl, followed by sonication on ice. After centrifugation, the supernatants were loaded on a TALON metal affinity column (Clontech). Recombinant proteins were eluted with the same buffer including 200 mM imidazole. The eluted proteins were dialyzed against 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM dithiothreitol, 10% glycerol, and 0.5 mM PMSF and were stored at Ϫ80°C until use. EMSAs. pri-let-7a-1, pre-let-7a-1, and pri-miR-21 were amplified from 293T cDNA by PCR with specific primers. The PCR products were subcloned into the pGEM-T-easy vector (Promega). The plasmids were linearized with SpeI and used for in vitro transcription to make 32 P-radiolabeled RNA probes. An electrophoretic mobility shift assay (EMSA) was performed in a 20-l reaction mixture containing 50 mM Tris-HCl, pH 7.6, 100 mM NaCl, 5% glycerol, 2 mM MgCl 2 , 0.2% bovine serum albumin, 20 units of RNase Out (Invitrogen), 30 g yeast Saccharomyces cerevisiae tRNA, and ϳ25,000 cpm labeled probe. The mixture was incubated at 0°C for 15 min and then electrophoresed on a 4% polyacrylamide gel containing 10% glycerol in 0.5ϫ Tris-borate-EDTA. For supershift assays, recombinant proteins were preincubated with antibodies at 0°C for 20 min followed by the addition of the labeled probe. Images were captured and intensities of specific bands were measured using a BAS-2500 imaging system (Fuji Film).
Cell viability assay. Three days posttransfection, siRNA-transfected 293 cells were seeded at 1,000 cells/well in 96-well plates. Viability of the cells following 0, 1, 3, and 4 days of culture was assayed by staining with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) reagent (Promega) and measuring the optical density at 490 nm.
RESULTS
Overexpression of NF90 and NF45 inhibits the processing step to produce pre-miRNA during miRNA biogenesis. To examine the effect of the NF90 and NF45 proteins on the Drosha-mediated processing step in miRNA biogenesis, we performed an in vitro pri-miRNA processing assay. WCEs were prepared from 293T cells transfected with expression plasmids for the NF90 family (NF90a, NF90b, NF110a, or NF110b) and/or NF45. After radiolabeled pri-miR-30a was incubated with WCEs and RNAs were extracted and loaded onto a denaturing gel (Fig. 1A) . The levels of pre-miR-30a were measured with a densitometer (Fig. 1B) . This analysis showed that simultaneous expression of the NF90 and NF45 proteins markedly inhibited the cleavage of pri-miR-30a to pre-miR-30a (Fig. 1A , compare lanes 2 to 7 and 8 to 11, and B). In contrast, neither NF90 nor NF45 alone affected the processing step relative to the mock-transfected control (Fig.  1A , compare lane 2 and lanes 3 to 7, and B). Immunoblot analysis showed that expression of Drosha and DGCR8, which play a critical role in cleavage of pri-miRNA to pre-miRNA, was not altered by the overexpression of the NF90 and/or NF45 proteins (Fig. 1C) . These results suggest that the NF90-NF45 complex may function as a negative regulator in the processing step to produce pre-miRNA during miRNA biogenesis.
Pri-miRNAs accumulate in mammalian cells that overexpress NF90 and NF45. To assess the ability of the NF90-NF45 complex to function as a negative regulator in the pri-miRNA processing step, we measured the levels of pri-miRNAs in cells that overexpressed NF90 and/or NF45. 293T cells were transfected with expression plasmids for mock transfection or NF45 and/or NF90. RNAs were extracted and analyzed by qRT-PCR with specific primers for three different, randomly chosen primiRNAs. ␤-Actin was used as an internal control. Cells transfected with NF45 did not show induction of pri-miRNAs, and the forced expression of NF90 resulted in a slight increase in the pri-miRNAs (Fig. 2) . Importantly, the amounts of all primiRNAs were strikingly increased by overexpression of both the NF90 and NF45 proteins (Fig. 2) , whereas ␤-actin expression was not affected by these proteins (Fig. 2 , compare A to C with D). These results indicate that pri-miRNAs specifically accumulated upon overexpression of NF90 and NF45. We also measured the levels of mature miRNAs, which were processed from the pri-miRNAs analyzed in the experiment shown in Fig.  2 , in NF90-NF45-overexpressing cells. However, we could not observe any significant change in miRNA production by the overexpression of NF90, either with or without NF45 (data not shown). Several previous studies reported that mature miRNAs are highly stable in cells (33, 40) . Therefore, a decrease of mature miRNAs at a steady-state level may be difficult to detect.
We next tested whether the increase in pri-miRNAs by NF90-NF45 overexpression is due to transcriptional activation. For this purpose, we used a universal inhibitor of RNA polymerase II, ␣-amanitin. Cells were mock transfected or transfected with both NF90b and NF45 plasmids and subsequently treated with ␣-amanitin for 0, 6, 12, and 24 h. RNAs were prepared from the cells and analyzed by RT-qPCR with specific primers for selected pri-miRNAs. These analyses indicated that all the pri-miRNAs examined were significantly decreased in mock-transfected cells treated with ␣-amanitin for 12 h (Fig. 3A and B) or 24 h (Fig. 3C) , indicating that the steady-state levels of pri-miRNAs are maintained by transcriptional activation. In contrast, the ␣-amanitin treatment of cells overexpressing NF90b and NF45 did not significantly reduce the levels of pri-miRNAs (Fig. 3) , suggesting that transcriptional activation is not the sole factor for the elevation of pri-miRNAs by NF90-NF45 overexpression. These findings together with results of the in vitro pri-miRNAs processing assay ( Fig. 1) suggest that the inhibition of the Drosha-mediated pri-miRNAs processing step by the NF90-NF45 complex caused the accumulation of pri-miRNAs.
A previous study indicated that overexpressed Drosha associates with NF90 and NF45 (13) . This finding prompted us to examine whether the accumulation of pri-miRNAs by overexpressed NF90-NF45 is influenced by the forced expression of Drosha. However, no significant change in the accumulated level of pri-miRNAs was observed in cells transfected with NF90-NF45 and Drosha compared with NF90-NF45-overexpressing cells (Fig. 4A) . We verified that Drosha was expectedly overexpressed upon transfection at the RNA and protein levels (Fig. 4B) . These results suggest that overexpressed NF90-NF45 may disturb the accessibility of Drosha to primiRNAs.
NF90 is retained in the nucleus during overexpression of the NF90-NF45 complex. To examine the subcellular localization of the NF90 family proteins in cells that overexpressed NF90 and NF45, we performed immunocytochemical staining. 293T cells were mock transfected or transfected with plasmids for NF90b or both NF90b and NF45 and stained with DAPI for nuclear staining (Fig. 5 , upper panels) and anti-NF90 antibody (Fig. 5, middle panels) . The lower panels show overlays of these two signals (Fig. 5, merge) . As previously reported, endogenous NF90 proteins were predominantly localized in the nucleus (Fig. 5, first column) . Importantly, enforced expression of NF90b or both NF90b and NF45 did not affect the nuclear localization of the NF90 family proteins (Fig. 5, second and  third columns) . This indicates that the NF90 family proteins are retained in the nucleus, even if NF90 and NF45 are excessively expressed.
NF90 does not interact with the endogenous Drosha-DGCR8 complex, but the NF90-NF45 complex binds endogenous pri-miRNAs. To test whether the NF90 proteins associate with endogenous Drosha in vivo, WCEs were prepared from 293T cells that were mock transfected or transfected with plasmids for both NF90b and NF45 and subjected to immunoprecipitation with anti-Drosha antibody or normal rabbit IgG. The immunoprecipitates were analyzed by Western blotting with anti-Drosha, anti-DGCR8, or anti-NF90 antibodies. As expected, Drosha interacted with DGCR8 in mock-transfected cells and cells transfected with both NF90b and NF45 (Fig. 6A , middle panels). However, NF90 did not associate with the endogenous Drosha-DGCR8 complex in vivo (Fig. 6A , lower panel). To confirm these results, we carried out a blue native electrophoresis analysis, which is a powerful tool for analyzing native protein complexes. WCEs prepared from 293T cells that were mock transfected or transfected with both NF90b and NF45 were subjected to native PAGE and immunoblotting to determine whether the Drosha-DGCR8 complex and the NF90-NF45 complex are distinct. As shown in Fig. 6B , the mobility of the Drosha-containing complex was completely consistent with that of DGCR8, and the NF90-and NF45-containing complexes exhibited the same mobility (Fig. 6B) . These results show that Drosha forms a complex with DGCR8, while NF90 associates with NF45. However, the mobility of NF90-NF45 was clearly different from that of Drosha-DGCR8 (Fig. 6B ). These observations, together with previously reported data (13) , suggest that the NF90-NF45 complex is not included in the endogenous Drosha-DGCR8 complex, although forced expression of Drosha associates with NF90 and NF45 (13) . We next examined if the NF90-NF45 complex associates with endogenous pri-miRNAs in vivo. WCEs from 293T cells that were mock transfected or transfected with plasmids for Flagtagged NF90b and/or Flag-tagged NF45 were immunoprecipitated with anti-Flag antibody. RNAs were recovered from the immunoprecipitates and analyzed by RT-PCR with the specific primers for pri-miRNAs. All the pri-miRNAs examined were undetectable in no-template and no-reverse transcriptase samples (Fig. 7, lanes 5 to 9) . Of note, the NF90b-NF45 complex associ- ated with all pri-miRNAs (Fig. 7, lane 4) , whereas the NF45 or NF90b proteins alone were not able to bind to the majority of pri-miRNAs (Fig. 7, lanes 2 and 3) . Interestingly, the number of PCR cycles needed to detect pri-let-7a-1 was much lower than that for other pri-miRNAs tested (35, versus 45 for other primiRNAs), although the efficiency of PCR amplification for prilet-7a-1 was not higher than that for other pri-miRNAs. These results suggest that the higher amount of pri-let-7a-1 was associated with NF90-NF45 compared to other pri-miRNAs. In addition, we measured the absolute amounts of pri-miRNAs in cells transfected with NF90 and NF45 by qRT-PCR using plasmids harboring cDNA for pri-miRNAs as standards. The results indicated that the absolute amount of pri-let-7a-1 was about 3-to 30-fold higher than that of other pri-miRNAs (see Table S2 in the supplemental material), implying that overexpressed NF90-NF45 has the ability to associate with endogenous pri-miRNAs dependent on the abundance of each pri-miRNA.
The NF90-NF45 complex binds to pri-and pre-let-7a-1, and the affinity of NF90-NF45 complex for pri-let-7a-1 is higher than that of DGCR8 in vitro. To confirm the data from the in vivo RNA-protein binding analysis (Fig. 7) , we performed an EMSA using recombinant proteins. We generated recombinant NF90 (rNF90), rNF45, FL DGCR8, and dsRBDs of DGCR8 in E. coli (see Fig. S1A in the supplemental material) and used these proteins for an EMSA with pri-miRNAs or pre-miRNA probe. Immunoblot analysis with anti-DGCR8 antibody confirmed the existence of DGCR8 in our purified rDGCR8 FL sample (see Fig. S1A in the supplemental material). The EMSA probed with pri-let-7a-1 clearly showed that rNF90-rNF45 bound to these RNAs in vitro ( Fig. 8 ; see also Fig. S1B in the supplemental material) . However, we found two major bands in these analyses ( Fig. 8 ; see and RNAs, we carried out a supershift assay using anti-NF90 antibody. Addition of NF90 antibody resulted in the formation of supershifted complex with the upper band (see Fig. S1B , lanes 3 and 4, in the supplemental material), indicating that the upper band is the complex of rNF90-rNF45 with RNAs. Under this experimental condition, EMSA probed with pri-let-7a-1 and pri-miR-21 showed that the rNF90-rNF45 complex exhibited 4.3-fold-higher binding activity for pri-let-7a-1 than primiR-21 (see Fig. S1D , arrow, compare lanes 4 and 9, in the supplemental material). We next examined if the NF90-NF45 complex discriminates between pri-miRNAs and pre-miRNAs. An EMSA with pri-or pre-let-7a-1 indicated that the binding activity of the rNF90-rNF45 complex to pre-let-7a-1 was comparable to that of this complex to pri-let-7a-1 (Fig. 8A , compare lanes 2 and 6). Recent studies also showed that NF90, either with or without NF45, binds to pre-let-7 in vitro (23, 57) . Therefore, these results suggest that the NF90-NF45 complex selectively binds the stem-loop structure, which is a common secondary structure of pri-and pre-miRNAs. Furthermore, we tested whether the NF90-NF45 complex exhibits higher binding to pri-miRNA than with NF90 alone as shown in Fig. 7 . Figure 8B showed that the binding activity of rNF90-rNF45 to pri-let7a-1 was 1.8-fold higher than that of rNF90 alone (compare lanes 3 and 7). NF45 alone did not exhibit the binding to pri-let-7a-1 (Fig. 8B, lanes 4 and 5) . To confirm this result, we performed rNF45 titrations in the presence of rNF90. As expected, the binding activity of rNF90 was increased according to the elevation of rNF45 concentration, but not that of a control protein (GST) (see Fig. S1C in the supplemental material, compare lanes 2 to 4 and 5 to 7). Since the NF90-NF45 complex impairs pri-miRNA processing and binds to pri-miRNA while these proteins do not associate with endogenous Drosha-DGCR8, we hypothesized that the binding of NF90-NF45 to pri-miRNAs reduces the accessibility of Drosha-DGCR8 to pri-miRNAs, resulting in the inhibition of pri-miRNA processing. It is known that DGCR8 recognizes the substrate pri-miRNAs, whereas Drosha is responsible for cleavage in Drosha-DGCR8-mediated pri-miRNA processing (21) . Therefore, we compared the difference in the binding activity to prilet-7a-1 between NF90-NF45 and DGCR8. rDGCR8 FL showed two bands on the EMSA when probed with pri-let7a-1 (Fig. 8C, lanes 9 and 10) . Thus, we performed a supershift assay using anti-DGCR8 antibody, which recognizes the DGCR8 C-terminal region containing dsRBDs. In this analysis, both bands disappeared with the addition of anti-DCGR8 antibody (see Fig. S1B in the supplemental material, compare lanes 5 and 6 with 7 and 8), demonstrating that the two bands were the complex of rDGCR8 FL with primiRNA. Under this experimental condition, we compared the binding activities of rNF90-rNF45 and rDGCR8 FL to pri-miRNA. As shown in Fig. 8C, rNF90-rNF45 clearly ex- hibited a greater binding activity to pri-let-7a-1 than rDGCR8 FL (compare lanes 2 to 4 and 5 to 7). To confirm this result, we performed an EMSA using rDGCR8-dsRBDs. Titration of rDGCR8-dsRBDs indicated the formation of a complex between rDGCR8-dsRBDs and pri-let7a-1 (Fig. 8D ). As shown in Fig. 8E , the complex between rDGCR8-dsRBDs and pri-miRNA was replaced by the NF90-NF45-pri-miRNA complex at lower concentrations of rNF90-rNF45 (1.2 to 4.8 M) compared with that of rDGCR8-dsRBDs (9.6 M). These results suggest that NF90-NF45 might preferentially bind to pri-let-7a-1 even in the presence of Drosha-DGCR8 under the condition of NF90-NF45 overexpression.
Knockdown of NF90 leads to a reduction of pri-let-7a-1 and an increase of mature let-7a-1 and causes growth suppression of transformed cells. To confirm the function of the NF90-NF45 complex as a negative regulator in miRNA biogenesis, we measured the levels of pri-miRNAs and mature miRNAs which were produced from tested pri-miRNAs in NF90 knockdown cells. Transfection of siRNAs targeting the NF90 family proteins resulted in ϳ75% inhibition of the expression of endogenous NF90 family proteins (Fig. 9A) . As expected, we observed a significant decrease in pri-let-7a-1 in the NF90 knockdown cells (Fig. 9B) . In accordance with the decrease in pri-let-7a-1, mature let-7a was increased in cells that were depleted of NF90 (Fig. 9C) . However, knockdown of NF90 did not significantly affect the levels of other pri-miRNAs and mature miRNAs (Fig. 9B and C) . These results, together with protein-RNA binding assays (see Fig. S1D in the supplemental material), suggest that processing of pri-miRNAs having high affinity for the NF90-NF45 complex into mature miRNAs may be specifically prevented by these proteins.
Several reports have indicated that let-7a has a potent antiproliferative activity in cultured cell lines (1, 25) . This finding prompted us to test if NF90-NF45 participates in the control of cell proliferation. Knockdown of NF90 resulted in a significant reduction in growth rates of 293 cells (Fig. 10) . Since the level of mature let-7a was elevated in NF90 knockdown cells, as shown in Fig. 9C , these observations suggest that NF90-NF45 might control cell proliferation via the regulation of mature let-7a production.
DISCUSSION
The miRNA processing machinery has been relatively well characterized. The basic miRNA factors include Drosha, DGCR8, Exportin-5, Dicer, and Argonaute (Ago). In addition, p68 and p72 DEAD-box RNA helicase subunits, DDX5 and DDX17, human immunodeficiency virus transactivating response RNA binding protein, and PKR-activating protein have been reported as miRNA processing factors (6, 9, 18, 34) . Like NF90 and NF45, DDX5 and DDX17 associate with overexpressed Drosha (13), but DDX5 and DDX17 facilitate the Drosha-DGCR8-mediated pri-miRNA processing reaction (9) , while NF90 and NF45 inhibit the pri-miRNA processing (this study). Transactivating response RNA binding protein and PKR-activating protein function as bridging molecules between Dicer and Ago, but they do not show any effect on the Dicer processing reaction (6, 34) . Notably, knockdown of these proteins reduces mature miRNA production (6, 9, 34) , indicating that these miRNA processing factors are positive regulators for miRNA biogenesis. In contrast, negative regulatory events in the miRNA processing pathways are largely unknown.
In this study, we have shown that the forced expression of NF90 and NF45 impairs the Drosha-mediated pri-miRNA processing step in vitro (Fig. 1) . Furthermore, pri-miRNAs accumulated in cells that overexpressed NF90 and NF45, and the accumulation was not due to transcriptional activation ( Fig. 2  and 3) . Interestingly, the enforced expression of Drosha, which plays a crucial role in cleavage of pri-miRNA to pre-miRNA, had no apparent effect on the accumulation (Fig. 4) . In addition, the NF90-NF45 complex did not interact with the endogenous Drosha-DGCR8 complex (Fig. 6 ). On the other hand, in vivo and in vitro RNA-protein binding assays demonstrated that the NF90-NF45 complex bound to pri-miRNAs ( Fig. 7 and 8; see also Fig. S1 in the supplemental material). Particularly, pri-let-7a-1 was found to show higher binding with NF90-NF45 than pri-miR-21 (see Fig. S1D in the supplemental material). Notably, knockdown of NF90 caused the decrease of pri-let-7a-1 and the increment in mature let-7a (Fig.   FIG. 9 . Knockdown of NF90 decreases pri-miRNA and increases mature miRNA. (A) WCEs were prepared from 293 cells transfected with the indicated siRNAs and analyzed by immunoblotting with anti-NF90 and anti-␣-tubulin antibodies. Intensities of specific bands were measured with a densitometer and are presented as relative band intensities. (B) RNAs were isolated from 293 cells transfected with the indicated siRNAs and analyzed for the amount of pri-miRNAs by qRT-PCR with specific primers for pri-let-7a-1, pri-miR-21 and pri-miR-15aϳ16-1. ␤-Actin was used as an internal control and for normalization of the data. siCTL, negative control siRNA; siNF90-1 and -2, siRNA targeting NF90. These results were reproducible in two independent transfection experiments. Data represent the averages of triplicate PCRs with ranges. P values were calculated by a two-tailed Student's t test. (C) RNAs were isolated from 293 cells transfected with the indicated siRNAs and analyzed for the amount of mature let-7a, miR-21 and miR-15a miRNAs using the TaqMan microRNA assay. RNU6B was used as an internal control and for normalization of the data. These results were reproducible in two independent transfection experiments. Data represent the averages of triplicate PCRs with ranges. P values were calculated by the two-tailed Student's t test.
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SAKAMOTO ET AL. MOL. CELL. BIOL. 9). Therefore, these findings suggest that the binding of NF90-NF45 to pri-miRNAs may reduce the accessibility of the Microprocessor complex to pri-miRNAs, resulting in the reduction of miRNA production. The NF90 and NF45 mRNAs are ubiquitously expressed in human and murine tissues (50, 60) . However, protein expression levels of NF90 and NF45 are restricted. In both humans and mice, the NF90 family proteins are minimally expressed in lung, spleen, skeletal muscle, kidney, and liver, whereas high expression is seen in brain, testis, ovary, and thymus (50, 52) (S. Sakamoto, unpublished data). NF45 is also minimally expressed in heart, lung, spleen, skeletal muscle, and liver, but it is abundantly expressed in brain, testis, kidney, and thymus (60; Sakamoto, unpublished). The highest amounts of both proteins are seen in immortalized cell lines derived from uterus, kidney, leukocyte, fibroblast, stomach, and liver (50, 60; Sakamoto, unpublished) . These observations suggest that the expression of the NF90 and NF45 proteins in undifferentiated cells may be much higher than that in differentiated cells. Indeed, the thymus and testis, in which the highest levels of the NF90 and NF45 proteins are seen, are comprised largely of cells undergoing differentiation, while lung, spleen, skeletal muscle, kidney, and liver are comprised largely of terminally differentiated cells. Furthermore, our previous results showed that higher levels of NF90 expression were detected in undifferentiated leukemia cells compared with phorbol ester-induced differentiated cells (47) .
Numerous studies have demonstrated that miRNAs are associated with tumorigenesis. It is noteworthy that expression of a high copy number of miRNAs is reduced in tumor tissues and in transformed cell lines compared with normal tissues (10, 39) . Interestingly, primary miRNA transcripts are not reduced in tumors, suggesting that the reduction of miRNAs in cancers is due to the altered regulation of the pri-miRNA processing (56) . In fact, knockdown of Drosha, DGCR8, or Dicer, which are crucial factors for pri-and pre-miRNA processing, enhances tumor formation (30) . However, expression of these factors is not dependent upon cytodifferentiation (39, 56) . These observations suggest that the reduction of miRNAs in tumors might be due either to posttranslational modifications of the miRNA processing machinery or to the involvement of another miRNA-processing regulatory factor(s). let-7 miRNA, which is a founding member of the miRNA family, is composed of 12 variants, let-7a-1 to let-7i and miR-98. Among them, mature let-7a, -7d, -7f-1, -7f-2, -7i, and miR-98 are detectable only in highly differentiated human and mouse embryonic cells, although the primary transcripts of those miRNAs are expressed in both undifferentiated and differentiated cells (54, 56) . Several studies also reported that the level of let-7 family is decreased in tumor tissues compared with adjacent normal tissues (1, 26, 55, 59) and has the ability to inhibit proliferation of transformed cell lines (1, 25) . Furthermore, it is known that a decrease in the level of let-7 family causes an increase in the expressions of RAS, c-MYC, and HMGA2, resulting in tumorigenesis (1, 26, 37, 42, 49) . It has been thought that the alteration of let-7 family level according to cytodifferentiation is due to posttranscriptional regulation (54, 56) . Indeed, recent studies reported that lin28 functions as a negative regulator for production of mature let-7 family by blockade of Drosha processing or Dicer processing (23, 57) .
The present study has shown that depletion of NF90 results in a reduction of pri-let-7a-1 accompanied by an increase in mature let-7a (Fig. 9 ) and growth retardation in transformed cells (Fig. 10) . A recent study also indicated that growth suppression is observed in NF90 or NF45 knockdown HeLa cells (15) . Analyses of NF90 and NF45 expression profiles suggest that these proteins could be more highly expressed in undifferentiated than differentiated cells (47, 50, 52, 60) . In addition, we have found that NF90-NF45 expression exhibits significant elevation in human tumor tissues bearing hepatocellular carcinoma compared with adjacent normal tissues (unpublished data). The elevation of NF90 has been also found in lung cancer tissues (16) . Moreover, mature let-7a is downregulated in lung cancer and hepatocellular carcinoma compared with adjacent normal tissues or liver cirrhosis (11, 26, 55; Sakamoto, unpublished) . It is therefore possible that the repression of let-7 is likely due to the high expression of the NF90 and NF45 proteins in tumor cells, together with lin28, resulting in the accelerated growth of the cells. Elucidation of the roles for these proteins in the downregulation of let-7, followed by the control of cell growth in tumors, will be of interest but will require extensive work in the future. 
